INOVIO PHARMACEUTICALS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
INOVIO PHARMACEUTICALS, INC. (INO) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $253.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2023-05-10
- 2023-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $253.00K.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $273.00K.
- 2022-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $272.00K.
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $272.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2023-03-31 | $253.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $273.00K 10-K · filed 2023-03-01 |
| 2022-09-30 | $272.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $272.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $276.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $493.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $493.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $493.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $493.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $521.00K 10-K · filed 2021-03-01 |
| 2020-09-30 | $520.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $520.00K 10-Q · filed 2020-08-10 |
| 2019-12-31 | $547.08K 10-K · filed 2020-03-12 |
| 2018-12-31 | $1.07M 10-K · filed 2019-03-12 |
| 2017-12-31 | $1.25M 10-K · filed 2018-03-14 |
| 2016-12-31 | $1.62M 10-K · filed 2017-03-15 |
| 2015-12-31 | $815.24K 10-K · filed 2016-03-14 |
| 2014-12-31 | $870.20K 10-K · filed 2015-03-16 |
| 2013-12-31 | $943.00K 10-K · filed 2014-03-17 |
| 2012-12-31 | $1.77M 10-K · filed 2013-03-18 |
| 2012-09-30 | $1.80M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $1.80M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |